Gufic Biosciences Balance Sheet Health
Financial Health criteria checks 4/6
Gufic Biosciences has a total shareholder equity of ₹5.3B and total debt of ₹3.2B, which brings its debt-to-equity ratio to 59.5%. Its total assets and total liabilities are ₹10.9B and ₹5.6B respectively. Gufic Biosciences's EBIT is ₹1.3B making its interest coverage ratio 8.4. It has cash and short-term investments of ₹134.8M.
Key information
59.5%
Debt to equity ratio
₹3.17b
Debt
Interest coverage ratio | 8.4x |
Cash | ₹134.84m |
Equity | ₹5.33b |
Total liabilities | ₹5.60b |
Total assets | ₹10.93b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 509079's short term assets (₹6.0B) exceed its short term liabilities (₹3.7B).
Long Term Liabilities: 509079's short term assets (₹6.0B) exceed its long term liabilities (₹1.9B).
Debt to Equity History and Analysis
Debt Level: 509079's net debt to equity ratio (57%) is considered high.
Reducing Debt: 509079's debt to equity ratio has reduced from 129.7% to 59.5% over the past 5 years.
Debt Coverage: 509079's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 509079's interest payments on its debt are well covered by EBIT (8.4x coverage).